Workflow
路德环境(688156) - 2024 Q3 - 季度财报
688156Road Environment(688156)2024-10-25 09:49

Financial Performance - The company's operating revenue for Q3 2024 was ¥76,694,460.46, a decrease of 28.02% compared to the same period last year[2]. - The net profit attributable to shareholders was -¥4,948,419.09, representing a decline of 133.60% year-on-year[2]. - The net profit after deducting non-recurring gains and losses was -¥5,539,400.33, down 143.47% from the previous year[2]. - The company reported a net profit of -¥3,444,028.64 for the first nine months of 2024, a decrease of 113.07% compared to the same period last year[5]. - The net profit attributable to shareholders for the current reporting period decreased by 133.60% due to increased sales, management, and financial expenses[10]. - The net profit attributable to shareholders for the year-to-date period decreased by 113.07%, impacted by external factors and increased credit impairment losses of 4.4764 million RMB[10]. - The net profit excluding non-recurring gains and losses for the current period decreased by 143.47% due to a decline in operating income and fixed costs not being diluted[10]. - The company reported a total comprehensive loss of CNY 7,954,409.81 for the first three quarters of 2024, compared to a comprehensive income of CNY 28,707,120.14 in the same period of 2023[20]. - Net profit for the first three quarters of 2024 was a loss of CNY 7,954,409.81, compared to a profit of CNY 28,707,120.14 in the same period of 2023[19]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,737,782,582.12, an increase of 9.33% compared to the end of the previous year[3]. - Total assets at the end of the reporting period increased by 9.33% as a result of debt financing for fixed asset reinvestment[10]. - Current assets totaled RMB 692,893,601.42, down from RMB 765,445,931.35[15]. - Total liabilities increased to RMB 805,192,709.14 from RMB 643,345,534.89[17]. - The company's equity attributable to shareholders decreased to RMB 888,153,752.60 from RMB 896,893,683.89[17]. - The company reported a decrease in undistributed profits to RMB 190,309,674.13 from RMB 198,789,410.62[17]. Cash Flow - The net cash flow from operating activities for the year-to-date period increased by 3,326.01%, primarily due to shorter credit terms in the sales of biopharmaceutical feed[10]. - The company reported a significant increase in cash received from sales of goods and services, amounting to an increase of 56.5094 million RMB compared to the previous year[10]. - Total cash inflow from operating activities was CNY 320,876,903.29, compared to CNY 293,710,630.40 in the previous year, showing an increase in cash generation from operations[21]. - The net cash flow from investing activities was -199,072,704.82,comparedto199,072,704.82, compared to -217,640,626.24 in the previous period[22]. - Total cash inflow from financing activities amounted to 353,092,344.09,anincreasefrom353,092,344.09, an increase from 276,425,471.92 in the prior period[22]. - The net cash flow from financing activities was 207,893,636.09,upfrom207,893,636.09, up from 194,533,605.98 year-over-year[22]. - The company experienced a net increase in cash and cash equivalents of 58,169,885.84,contrastingwithadecreaseof58,169,885.84, contrasting with a decrease of 24,636,741.80 in the previous period[22]. Research and Development - The company's R&D investment totaled ¥3,346,086.84, a decrease of 21.45% year-on-year, while the R&D investment as a percentage of operating revenue increased to 4.36%[3]. - Research and development expenses were CNY 9,988,077.91, slightly up from CNY 9,636,236.31 in the previous year[19]. Business Operations - The sales volume of the company's liquor lees fermentation feed business reached 81,100 tons, an increase of 22.98% year-on-year, contributing ¥168,608,000 in sales revenue, up 20.92%[5]. - The inorganic solid waste treatment service business generated revenue of ¥35,413,000, a decline of 57.94% year-on-year, due to reduced project initiation rates in the environmental protection industry[5]. - The company is focusing on the rapid development of its biopharmaceutical feed business, which is expected to continue driving growth[10]. - The company is facing challenges in its engineering sludge treatment services due to a downturn in the real estate construction industry, leading to a significant reduction in sludge intake and disposal[10]. Expenses - The company experienced increased sales, management, and financial expenses due to expansion efforts and new factory operations, impacting overall profitability[6]. - Total operating costs increased to CNY 225,754,641.74, up 12% from CNY 201,614,202.23 in the previous year[18]. - Sales expenses increased to CNY 15,844,825.97 from CNY 4,751,196.47 in the previous year, indicating a rise in marketing efforts[19]. Earnings Per Share - Basic earnings per share for the current period was -126.67 RMB, reflecting the decrease in net profit attributable to shareholders[10]. - Diluted earnings per share for the year-to-date period was -111.11 RMB, also reflecting the decrease in net profit attributable to shareholders[10]. - Basic and diluted earnings per share for the first three quarters of 2024 were both CNY -0.03, down from CNY 0.27 in the previous year[20]. Accounting and Reporting - The company did not apply new accounting standards for the current financial report[23]. - The report was published on October 25, 2024, indicating the company's commitment to timely financial disclosures[23].